Phoenix Biotech Acquisition Insiders
PBAXDelisted Stock | USD 10.90 0.00 0.00% |
Phoenix Biotech employs about 4 people. The company is managed by 4 executives with a total tenure of roughly 10 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Break down of Phoenix Biotech's management performance can provide insight into the company performance.
Phoenix |
Phoenix Biotech Management Team Effectiveness
The company has return on total asset (ROA) of (0.0255) % which means that it has lost $0.0255 on every $100 spent on assets. This is way below average. Phoenix Biotech's management efficiency ratios could be used to measure how well Phoenix Biotech manages its routine affairs as well as how well it operates its assets and liabilities.Phoenix Biotech Workforce Comparison
Phoenix Biotech Acquisition is considered to be number one stock in number of employees category among its peers. The total workforce of Financials industry is at this time estimated at about 12.0. Phoenix Biotech totals roughly 4.0 in number of employees claiming about 33% of equities under Financials industry.
Phoenix Biotech Notable Stakeholders
A Phoenix Biotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Phoenix Biotech often face trade-offs trying to please all of them. Phoenix Biotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Phoenix Biotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
MD MBA | President | Profile | |
Daniel MBA | Chief Officer | Profile | |
Christopher MBA | CEO Director | Profile | |
MBA MBA | Chief Officer | Profile |
About Phoenix Biotech Management Performance
The success or failure of an entity such as Phoenix Biotech Acqu often depends on how effective the management is. Phoenix Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Phoenix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Phoenix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Phoenix Biotech Acquisition Corp. does not have significant operations. The company was incorporated in 2021 and is based in Oakland, California. Phoenix Biotech is traded on NASDAQ Exchange in the United States.
Please note, the imprecision that can be found in Phoenix Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Phoenix Biotech Acquisition. Check Phoenix Biotech's Beneish M Score to see the likelihood of Phoenix Biotech's management manipulating its earnings.
Phoenix Biotech Workforce Analysis
Traditionally, organizations such as Phoenix Biotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Phoenix Biotech within its industry.Phoenix Biotech Manpower Efficiency
Return on Phoenix Biotech Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 629K | |
Net Loss Per Executive | 629K | |
Working Capital Per Employee | 2.9M | |
Working Capital Per Executive | 2.9M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Phoenix Stock
If you are still planning to invest in Phoenix Biotech Acqu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Phoenix Biotech's history and understand the potential risks before investing.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |